FDA Inspection 1312804 — Sun Pharma Canada Inc.
The FDA completed an inspection of Sun Pharma Canada Inc. on Mar 27, 2026 in Brampton. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 27, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Brampton (Canada)